Solventum Corp. has agreed to buy Acera Surgical, a maker of regenerative wound care technology, for as much as $850 million.
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback